Pacer Advisors, Inc. Global Blood Therapeutics, Inc. Transaction History

Pacer Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$32.46 - $43.42 $57,519 - $76,940	-1,772 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$38.94 - $50.85 $57,553 - $75,156	-1,478 Reduced 45.48%	1,772 $72,000
Q4 2020 Jan 20, 2021	BUY	$37.65 - $63.77 $59,261 - $100,373	1,574 Added 93.91%	3,250 $141,000
Q3 2020 Oct 19, 2020	BUY	$52.76 - $74.49 $88,425 - $124,845	1,676 New	1,676 $92,000
Q4 2018 Feb 13, 2019	SELL	$31.54 - $46.67 $183,152 - $271,012	-5,807 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$38.0 - $51.1 $220,666 - $296,737	5,807 New	5,807 $221,000
Q1 2018 May 14, 2018	SELL	$39.6 - $65.9 $77,220 - $128,505	-1,950 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$29.7 - $45.7 $57,915 - $89,115	1,950	1,950 $77,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.